Timasheva, Y.,
Balkhiyarova, Z.,
Avzaletdinova, D.,
Rassoleeva, I.,
Morugova, T.V.,
Korytina, G.,
Prokopenko, I.,
Kochetova, O. (2023) ability of the model containing polygenic
scores for the variants associated with T2D in our dataset
LEGG, L.A.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.A.,
DENNIS, M.,
MEAD, G.E.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J (2019) , trials had to collect data on at least one of our primary (disability
score or independence) or secondary
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) The polygenic
scores (PGSs) are developed to help clinicians in distinguishing individuals at high
Pang, HY,
Zhang, WH,
Liang, XW,
Zhang, ZQ,
Chen, XL,
Zhao, LY,
Liu, K,
Galiullin, D,
Yang, K,
Chen, XZ,
Hu, JK (2021) markers and develop an effective prognostic
score system to predict the prognosis of GC patients.
Methods